Journal article

Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer disease

Fen Wang, Brian A Gordon, Davis C Ryman, Shengmei Ma, Chengjie Xiong, Jason Hassenstab, Alison Goate, Anne M Fagan, Nigel J Cairns, Daniel S Marcus, Eric McDade, John M Ringman, Neill R Graff-Radford, Bernardino Ghetti, Martin R Farlow, Reisa Sperling, Steve Salloway, Peter R Schofield, Colin L Masters, Ralph N Martins Show all

Neurology | LIPPINCOTT WILLIAMS & WILKINS | Published : 2015

Grants

Awarded by NIA


Awarded by JO & JR Wicking Trust


Awarded by NIH


Awarded by National Natural Science Foundation of China


Awarded by NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES


Awarded by NATIONAL INSTITUTE ON AGING


Awarded by National Institute for Health Research


Funding Acknowledgements

The DIAN is supported by NIA grant U19 AG032438 to J.C. Morris and by the generous support of F. Simmons and O. Mohan and an anonymous foundation, in addition to DIAN site support from the German Center for Neurodegenerative Diseases (DZNE), the NIHR Queen Square Dementia Biomedical Research Unit, and JO & JR Wicking Trust grants 13026 & 20821. The DIAN-TU (R.J. Bateman, PI) is supported by funding from the NIH U-01-AG042791, Alzheimer's Association, and the DIAN Pharma Consortium (Biogen, Eisai, Elan, Eli Lilly, Forum, Genentech, Hoffman La-Roche, Janssen, Mithridion, Novartis, Pfizer, and Sanofi-Aventis). The authors acknowledge Chinese Society of Neurology, the National Key Department of Neurology funded by Chinese Health and Family Planning Committee, and the National Natural Science Foundation of China (81100797) for their support for this study.